SCM
BIIB icon

Segantii Capital Management’s Biogen BIIB Stock Holding History

Segantii Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500
Closed -$12M – 623
2021
Q4 		$12M Buy
+500
New +$129K 0.37% 47

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Segantii Capital Management's BIIB Position: Q3 2023 in Review

Segantii Capital Management sold out of Biogen (BIIB) in Q3 2023, closing a stake of 100,000 shares — an estimated $28.5M sold.

Segantii Capital Management first reported a position in BIIB in Q4 2020 and held it in 8 quarters. The position peaked at $28.5M in Q2 2023. 966 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Segantii Capital Management reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Segantii Capital Management sold 100,000 Biogen shares in Q3 2023, an estimated $28.5M.
  • Segantii Capital Management first reported a position in Biogen in Q4 2020 and held it in 8 quarters.
  • Segantii Capital Management's Biogen position peaked at $28.5M in Q2 2023.
  • 966 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Segantii Capital Management's 13F filing for Q3 2023, filed 7 Nov 2023.